Concepedia

Seyed Hesamaldin Hejazi

SH

6

Publications

139

Citations

6

H-Index

2014

Active since

Affiliations

National Institute of Genetic Engineering and Biotechnology(Current)

Qom Islamic Azad University

Shahrekord University

Academic Center for Education, Culture and Research

Lorestan University

Seyed Hesamaldin Hejazi is an author at National Institute of Genetic Engineering and Biotechnology specializing in tumor microenvironment, cancer research, and breast cancer.

ORCID

Top concepts

Publications per year

2014–2020

6

Publications

6

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

Majid Pornour, Ghasem Ahangari, Seyed Hesamaldin Hejazi et al. · Recent Patents on Anti-Cancer Drug Discovery · 2015 · 36 citations

Dopamine Receptor Gene (DRD1-DRD5) Expression Changes as Stress Factors Associated with Breast Cancer

Majid Pornour, Ghasem Ahangari, Seyed Hesamaldin Hejazi et al. · Asian Pacific Journal of Cancer Prevention · 2015 · 34 citations · Full text

, , +15

Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line

Seyed Hesamaldin Hejazi, Ghasem Ahangari, Abdolkhaegh Deezagi · Current Drug Discovery Technologies · 2016 · 28 citations

Evaluation of Gene Expression Changes of Serotonin Receptors, 5-HT3AR and 5-HT2AR as Main Stress Factors in Breast Cancer Patients

Seyed Hesamaldin Hejazi, Ghasem Ahangari, Majid Pornour et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 17 citations · Full text

, , +17

Evaluation of serotonin receptors (5HTR2A and 5HTR3A) mRNA expression changes in tumor of breast cancer patients.

Zahra Olfati, Garshasb Rigi, Hajar Vaseghi et al. · PubMed · 2020 · 12 citations · Full text

Rows per page

1–5 of 6